Jade Biosciences, Inc. (JBIO)
20.07
-1.33
(-6.21%)
USD |
NASDAQ |
Sep 03, 14:14
Jade Biosciences 1 Year Total Returns (Daily) : 180.8% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 180.8% |
| September 01, 2026 | 166.1% |
| August 31, 2026 | 170.4% |
| August 28, 2026 | 157.9% |
| August 27, 2026 | 167.8% |
| August 26, 2026 | 165.6% |
| August 25, 2026 | 176.5% |
| August 24, 2026 | 159.2% |
| August 21, 2026 | 189.2% |
| August 20, 2026 | 209.9% |
| August 19, 2026 | 206.4% |
| August 18, 2026 | 214.0% |
| August 17, 2026 | 218.6% |
| August 14, 2026 | 265.0% |
| August 13, 2026 | 224.8% |
| August 12, 2026 | 214.1% |
| August 11, 2026 | 202.0% |
| August 10, 2026 | 190.1% |
| August 07, 2026 | 200.0% |
| August 06, 2026 | 184.0% |
| August 05, 2026 | 173.3% |
| August 04, 2026 | 192.9% |
| August 03, 2026 | 177.9% |
| July 31, 2026 | 174.7% |
| July 30, 2026 | 190.7% |
| Date | Value |
|---|---|
| July 29, 2026 | 157.0% |
| July 28, 2026 | 154.2% |
| July 27, 2026 | 140.9% |
| July 24, 2026 | 141.1% |
| July 23, 2026 | 125.3% |
| July 22, 2026 | 121.0% |
| July 21, 2026 | 136.2% |
| July 20, 2026 | 107.7% |
| July 17, 2026 | 119.3% |
| July 16, 2026 | 132.5% |
| July 15, 2026 | 154.8% |
| July 14, 2026 | 137.1% |
| July 13, 2026 | 116.9% |
| July 10, 2026 | 99.14% |
| July 09, 2026 | 113.9% |
| July 08, 2026 | 115.0% |
| July 07, 2026 | 114.8% |
| July 06, 2026 | 91.20% |
| July 02, 2026 | 99.17% |
| July 01, 2026 | 101.1% |
| June 30, 2026 | 122.4% |
| June 29, 2026 | 140.6% |
| June 26, 2026 | 137.8% |
| June 25, 2026 | 107.5% |
| June 24, 2026 | 109.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Perspective Therapeutics, Inc. | -6.63% |
| Cue Biopharma, Inc. | 13.32% |
| Praxis Precision Medicines, Inc. | 695.5% |
| Opus Genetics, Inc. | 261.8% |
| Faeth Therapeutics, Inc. | 398.3% |